Afatinib Recruiting Phase 3 Trials for Head and Neck Squamous Cell Carcinoma (HNSCC) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs